Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 4
1969 2
1970 3
1973 1
1974 1
1984 1
1989 1
1990 5
1995 2
1996 1
1999 1
2001 3
2002 2
2003 3
2005 3
2006 7
2007 13
2008 11
2009 12
2010 8
2011 14
2012 14
2013 13
2014 7
2015 18
2016 14
2017 20
2018 28
2019 25
2020 28
2021 25
2022 33
2023 29
2024 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

321 results

Results by year

Filters applied: . Clear all
Page 1
Thyroid cancer.
Cabanillas ME, McFadden DG, Durante C. Cabanillas ME, et al. Among authors: durante c. Lancet. 2016 Dec 3;388(10061):2783-2795. doi: 10.1016/S0140-6736(16)30172-6. Epub 2016 May 27. Lancet. 2016. PMID: 27240885 Review.
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Filetti S, et al. Among authors: durante c. Ann Oncol. 2019 Dec 1;30(12):1856-1883. doi: 10.1093/annonc/mdz400. Ann Oncol. 2019. PMID: 31549998 Free article. No abstract available.
Contemporary Thyroid Nodule Evaluation and Management.
Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Grani G, et al. Among authors: durante c. J Clin Endocrinol Metab. 2020 Sep 1;105(9):2869-83. doi: 10.1210/clinem/dgaa322. J Clin Endocrinol Metab. 2020. PMID: 32491169 Free PMC article. Review.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Thyroid nodules: diagnosis and management.
Grani G, Sponziello M, Filetti S, Durante C. Grani G, et al. Among authors: durante c. Nat Rev Endocrinol. 2024 Dec;20(12):715-728. doi: 10.1038/s41574-024-01025-4. Epub 2024 Aug 16. Nat Rev Endocrinol. 2024. PMID: 39152228 Review.
International Expert Consensus on US Lexicon for Thyroid Nodules.
Durante C, Hegedüs L, Na DG, Papini E, Sipos JA, Baek JH, Frasoldati A, Grani G, Grant E, Horvath E, Hoang JK, Mandel SJ, Middleton WD, Ngu R, Orloff LA, Shin JH, Trimboli P, Yoon JH, Tessler FN. Durante C, et al. Radiology. 2023 Oct;309(1):e231481. doi: 10.1148/radiol.231481. Radiology. 2023. PMID: 37906014 Review.
ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer.
Filetti S, Durante C, Hartl DM, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Filetti S, et al. Among authors: durante c. Ann Oncol. 2022 Jul;33(7):674-684. doi: 10.1016/j.annonc.2022.04.009. Epub 2022 Apr 28. Ann Oncol. 2022. PMID: 35491008 Free article. No abstract available.
321 results